glp-1 receptor agonists brands list Costs Explained: Managing Coverage Challenges GLP-1 Receptor Agonist Market Size,
Description
GLP-1 is short for glucagon-like peptide-1

There's still plenty more to come this week (assuming I don't get completely lost in The Venetian), so make sure you're keeping up with CNBC's coverage

Davies, D

Tirzepatide came off the FDAs official drug shortage list in December 2024, and semaglutide followed in February 2025, eliminating the legal pathway that allowed compounding pharmacies to produce copies of the drugs

doi: 10.1016/j.neuropharm.2015.09.010

2020;161(12):bqaa201